GlassScriptPhysician profile
John Bisognano
NPI 1992747752
$26,212.96
in general payments reported to CMS, 2019-2025
9 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,750 · 2020: $3,238 · 2021: $1,296 · 2022: $8,761 · 2023: $2,380 · 2024: $8,588 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,440 · Consulting Fee: $4,528 · Food and Beverage: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,440.00 |
| Consulting Fee | $4,528.00 |
| Food and Beverage | $200.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Global Services, LLC | $7,399.24 | 2022 | |
| Idorsia Pharmaceuticals US INC | $6,440.00 | 2024 | Tryvio |
| Cvrx, INC. | $5,303.67 | 2020-2023 | Barostim Neo System |
| Welch Allyn | $4,200.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $2,233.53 | 2024-2025 | |
| Medtronic, INC. | $508.33 | 2021 | |
| Kestra Medical Technology Services, INC. | $80.34 | 2025 | Assure Wcd |
| Abbott Laboratories | $34.43 | 2025 | Triclip |
| Novartis Pharmaceuticals Corporation | $13.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bisognano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.